Improving the cost-effectiveness of cardiovascular disease prevention in Australia: a modelling study

被引：0
作者：
Linda J Cobiac
Anne Magnus
Jan J Barendregt
Rob Carter
Theo Vos
机构：
[1] University of Queensland,School of Population Health
[2] Deakin University,Deakin Health Economics, Strategic Research Centre – Population Health
来源：
BMC Public Health | / 12卷
关键词：
Absolute Risk; Ischaemic Heart Disease; Pharmaceutical Benefit Scheme; Stroke Event; Cardiovascular Disease Prevention;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 37 条
  • [1] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    CIRCULATION, 2016, 134
  • [2] Cost-Effectiveness Analysis of the Polypill Approach vs Periodic Risk Assessment for Prevention of Cardiovascular Disease
    Ferket, Bart S.
    Hunink, Myriam
    Khanji, Mohammed
    Agarwal, Isha
    Fleischmann, Kirsten E.
    Petersen, Steffen E.
    CIRCULATION, 2016, 134
  • [3] Horizon and Perspective: Critical Choices in Estimating Cost-Effectiveness of Cardiovascular Prevention
    Auer, Reto
    Kazi, Dhruv S.
    Earnshaw, Stephanie R.
    Pignone, Michael
    Pletcher, Mark J.
    CIRCULATION, 2012, 126 (21)
  • [4] Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas
    Hua Wang
    Donald Kenkel
    Meredith L. Graham
    Lynn C. Paul
    Sara C. Folta
    Miriam E. Nelson
    David Strogatz
    Rebecca A. Seguin
    BMC Health Services Research, 19
  • [5] Cost-effectiveness of a community-based cardiovascular disease prevention intervention in medically underserved rural areas
    Wang, Hua
    Kenkel, Donald
    Graham, Meredith L.
    Paul, Lynn C.
    Folta, Sara C.
    Nelson, Miriam E.
    Strogatz, David
    Seguin, Rebecca A.
    BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)
  • [6] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
    Lin, John K.
    Moran, Andrew E.
    Tobias, Andrea P.
    Kazi, Dhruv S.
    CIRCULATION, 2016, 134
  • [7] Cost-Effectiveness of a Fixed-Dose Combination Pill for Secondary Prevention of Cardiovascular Disease in China, India, Mexico, Ghana, and South Africa
    Lin, John K.
    Moran, Andrew E.
    Tobias, Andrea P.
    Kazi, Dhruv S.
    CIRCULATION, 2016, 134
  • [8] The cost-effectiveness analysis of a nationwide vitamin D supplementation program among Iranian adolescents for adulthood cardiovascular diseases prevention
    Zandieh, Narges
    Hemami, Mohsen Rezaei
    Darvishi, Ali
    Hasheminejad, Seyed Mohammad
    Abdollahi, Zahra
    Zarei, Maryam
    Heshmat, Ramin
    PUBLIC HEALTH, 2021, 198 : 340 - 347
  • [9] Cost-effectiveness of Financial Incentives for Improving Diet Through medicare and Medicaid
    Lee, Yujin
    Mozaffarian, Dariush
    Huang, Yue
    Liu, Junxiu
    Sy, Stephen
    Wilde, Parke E.
    Abrahams-Gessel, Shafika
    Jardim, Thiago V.
    Gaziano, Thomas A.
    Micha, Renata
    CIRCULATION, 2018, 137
  • [10] The Influence of Cost-Effectiveness Evaluations on Reimbursement in Australia: A Retrospective Study of Decisions made by the Pharmaceutical Benefits Advisory Committee
    Ngo P.
    Pharmaceutical Medicine, 2014, 28 (4) : 187 - 193
1234